The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
Open accessAbstract
We have speculated previously that the abrupt conversion from chronic stable to unstable angina and the continuum to acute myocardial infarction may result from myocardial ischemia caused by progressive platelet aggregation and dynamic vasoconstriction themselves caused by local increases in thromboxane and serotonin at sites of coronary artery stenosis and endothelial injury. Platelet aggregation and dynamic coronary artery vasoconstriction probably result from the local accumulation of thromboxane and serotonin and also relative decreases in the local concentrations of endothelially derived vasodilators and inhibitors of platelet aggregation, such as endothelium-derived relaxing factor (EDRF) and prostacyclin. With severe reductions in coronary blood flow caused by these mechanisms, platelet aggregates may increase, and an occlusive thrombus composed of platelets and white and red blood cells in a fibrin mesh may develop. When coronary arteries are occluded or narrowed for a sufficient period of time by these mechanisms, myocardial necrosis, electrical instability, or sudden death may occur. We believe that unstable angina and acute myocardial infarction are a continuum in relation to the process of coronary artery thrombosis and vasoconstriction. When the period of platelet aggregation or dynamic vasoconstriction at sites of endothelial injury and coronary artery stenosis is brief, unstable angina or non-Q wave infarction may occur. However, when the coronary artery obstruction by these mechanisms is prolonged for several hours, Q wave myocardial infarction results. Chronic endothelial injury and coronary artery stenosis are probably associated with the accumulation of platelets, white and red blood cells, and a fibrin mesh at the site of stenosis and endothelial injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
Ludmer, P. L., Selwyn, A. P., Shook, T. L., Wayne, R. R., Mudge, G. H., Alexander, R. W., & Ganz, P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610233151702 · Cited by 2,425
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Aspirin, Sulfinpyrazone, or Both in Unstable Angina: Results of a Canadian Multicenter Trial
Cairns, J. A., Gent, M., Singer, J., Finnie, K. J., Froggatt, G. M., Holder, D. A., Jablonsky, G., Kostuk, W. J., Melendez, L. J., Myers, M. G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511283132201 · Cited by 1,120
Coronary Angioscopy in Patients with Unstable Angina Pectoris
Sherman, C. T., Litvack, F., Grundfest, W., Lee, M., Hickey, A., Chaux, A., Kass, R., Blanche, C., Matloff, J., Morgenstern, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610093151501 · Cited by 872
Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
Folts, J. D., Crowell, E. B., & Rowe, G. G. (1976) · Circulation · doi:10.1161/01.cir.54.3.365 · Cited by 750
Hirsh, P. D., Hillis, L. D., Campbell, W. B., Firth, B. G., & Willerson, J. T. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103193041201 · Cited by 594
Self-citationAustin, G. E., Ratliff, N. B., Hollman, J., Tabei, S., & Phillips, D. F. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80174-1 · Cited by 574
Nabel, E. G., Ganz, P., Gordon, J. B., Alexander, R. W., & Selwyn, A. P. (1988) · Circulation · doi:10.1161/01.cir.77.1.43 · Cited by 555
Angiographic evolution of coronary artery morphology in unstable angina
Ambrose, J. A., Winters, S. L., Arora, R. R., Eng, A., Riccio, A., Gorlin, R., & Fuster, V. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80455-7 · Cited by 460
Cited by
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,321
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 995
The Prognostic Value of Serum Troponin T in Unstable Angina
Hamm, C. W., Ravkilde, J., Gerhardt, W., Jørgensen, P., Peheim, E., Ljungdahl, L., Goldmann, B., & Katus, H. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270302 · Cited by 953
Bertrand, M. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3385 · Cited by 900
Fuster, V (1994) · Circulation · doi:10.1161/01.cir.90.4.2126 · Cited by 848
Atherothrombosis and High-Risk Plaque
Fuster, V., Moreno, P. R., Fayad, Z. A., Corti, R., & Badimon, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 738
LICHTMAN, M., SPIVAK, J., BOXER, L., SHATTIL, S., & HENDERSON, E. (2000) · Hematology · doi:10.1016/b978-012448510-5/50164-3 · Cited by 605
JUULMOLLER, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92619-q · Cited by 517
Targeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
“The endothelium-derived vasodilators also possess anti-aggregatory properties, suppress thrombus formation, vascular stenosis (Willerson et al., 1989) and, in the case of the •NO/ cGMP axis, also retard cardiac hypertrophy (Ritchie et al., 2009).”
BackgroundFreedman, J. E., Parker, C., Li, L., Perlman, J. A., Frei, B., Ivanov, V., Deak, L. R., Iafrati, M. D., & Folts, J. D. (2001) · Circulation · doi:10.1161/01.cir.103.23.2792 · Cited by 475
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Golino, P., Piscione, F., Willerson, J. T., Cappelli-Bigazzi, M., Focaccio, A., Villari, B., Indolfi, C., Russolillo, E., Condorelli, M., & Chiariello, M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241001 · Cited by 426
Self-citationBertrand, M. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2301 · Cited by 410
Pristipino, C., Beltrame, J. F., Finocchiaro, M. L., Hattori, R., Fujita, M., Mongiardo, R., Cianflone, D., Sanna, T., Sasayama, S., & Maseri, A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1102 · Cited by 383
McFadden, E. P., Clarke, J. G., Davies, G. J., Kaski, J. C., Haider, A. W., & Maseri, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241002 · Cited by 360
Acute Coronary Syndromes: Unstable Angina and Non–Q-Wave Myocardial Infarction
Théroux, P., & Fuster, V. (1998) · Circulation · doi:10.1161/01.cir.97.12.1195 · Cited by 356
Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T., & Kovanen, P. T. (1999) · Circulation · doi:10.1161/01.cir.99.3.361 · Cited by 342
Dzau, V., & Braunwald, E. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90694-d · Cited by 322
Liao, J. K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.009 · Cited by 304
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty
Gawaz, M., Neumann, F.-J., Ott, I., Schiessler, A., & Schömig, A. (1996) · Circulation · doi:10.1161/01.cir.93.2.229 · Cited by 302
Gawaz, M., Neumann, F.-J., Dickfeld, T., Koch, W., Laugwitz, K.-L., Adelsberger, H., Langenbrink, K., Page, S., Neumeier, D., Schömig, A., et al. (1998) · Circulation · doi:10.1161/01.cir.98.12.1164 · Cited by 302
Regulation of Coronary Blood Flow
Goodwill, A. G., Dick, G. M., Kiel, A. M., & Tune, J. D. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160016 · Cited by 297
Serotonin Is Associated with Coronary Artery Disease and Cardiac Events
Vikenes, K., Farstad, M., & Nordrehaug, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.5.483 · Cited by 290
Storey, R. F., Sanderson, H. M., White, A. E., May, J. A., Cameron, K. E., & Heptinstall, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02208.x · Cited by 288
Acute coronary syndromes: biology
Fuster, V., Fayad, Z. A., & Badimon, J. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90234-9 · Cited by 283
Zeiher, A. M., Goebel, H., Schächinger, V., & Ihling, C. (1995) · Circulation · doi:10.1161/01.cir.91.4.941 · Cited by 280
Beyond lipid lowering: the role of statins in vascular protection
Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 266
Mikhed, Y., Daiber, A., & Steven, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715918 · Cited by 257
Annex, B. H., Denning, S. M., Channon, K., Sketch, M. H., Stack, R. S., & Peters, K. G. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)93041-a · Cited by 254
Toward a New Frontier in Myocardial Reperfusion Therapy: Emerging Platelet Preeminence
Topol, E. J. (1998) · Circulation · doi:10.1161/01.cir.97.2.211 · Cited by 253
Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein, D. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00322-8 · Cited by 151
Aspirin resistance and diabetes mellitus
Ajjan, R., Storey, R. F., & Grant, P. J. (2008) · Diabetologia · doi:10.1007/s00125-007-0898-3 · Cited by 79
Metadata
- Authors
- Willerson, J. T., Golino, P., Eidt, J., Campbell, W. B., & Buja, L. M.
- Venue
- Circulation
- Published
- 1989-07
- Volume
- 80
- Issue
- 1
- Pages
- 198-205
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2089406251
- Cited by
- 457
- References
- 24
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.